WED-392 Diagnostic and clinical implications of high spleen-to-liver stiffness ratio in MASLD – a prospective, comparative study
Christian Sebesta(Donauspital), David JM Bauer(Brigham and Women's Hospital), Nina Dominik(Medical University of Vienna), Benedikt Simbrunner(Medical University of Vienna), Lukas Hartl(Medical University of Vienna), Bernhard Scheiner(Medical University of Vienna), Michael Trauner(Medical University of Vienna), Thomas Reiberger(ERN GUARD-Heart), Benedikt Hofer(Austrian Academy of Sciences), Albert Friedrich Stättermayer(Medical University of Vienna), Mathias Jachs(Medical University of Vienna), Lorenz Balcar(Medical University of Vienna), Till Schöchtner(Medical University of Vienna), Friedrich Haimberger(Medical University of Vienna), Nicolas Balutsch(Medical University of Vienna), Mattias Mandorfer(Medical University of Vienna), Georg Kramer(Medical University of Vienna), Michael Schwarz(Medical University of Vienna)
Cited by 0
Related Papers
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
|Nature|2021|1.3k
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score
|Journal of Hepatology|2021|309
Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammation
|Journal of Hepatology|2024|239
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality
|Journal of Hepatology|2020|202
Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Cirrhosis
|Clinical Gastroenterology and Hepatology|2022|130